Afficher la notice abrégée

dc.rights.licenseopenen_US
dc.contributor.authorPENDA, C. I.
dc.contributor.authorTEJIOKEM, M. C.
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorSOFEU, Casimir
dc.contributor.authorNDIANG, S. T.
dc.contributor.authorATEBA NDONGO, F.
dc.contributor.authorKFUTWAH, A.
dc.contributor.authorGUEMKAM, G.
dc.contributor.authorWARSZAWSKI, J.
dc.contributor.authorFAYE, A.
dc.contributor.authorSTUDY GROUP, T. A.
dc.date.accessioned2020-07-09T08:33:06Z
dc.date.available2020-07-09T08:33:06Z
dc.date.issued2019-08
dc.identifier.issn2046-9055 (Electronic) 2046-9047 (Linking)en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/10251
dc.description.abstractEnBACKGROUND: Vertical (VT) transmission of HIV remains a public health concern in sub-Saharan Africa. OBJECTIVE: To investigate the VT rate and factors associated with transmission in routine practice in three referral hospitals in Cameroon. METHODS: All HIV-infected mothers who delivered in maternity wards or sought paediatric services during the first postnatal week from November 2007 to October 2010 were invited to participate in the ANRS-Pediacam cohort. Their infants were followed at 6, 10 and 14 weeks of life and HIV status was determined from the 6th week of life using real-time PCR. For those who were breastfed and negative at the first PCR, a second test was performed 6 weeks after breast-feeding was stopped. Logistic regression was performed to identify the independent risk factors of VT. RESULTS: Overall, 2053 HIV-exposed infants were enrolled. Of these, 1827 were tested for HIV including 1777 before the age of 3 months, and 59 were HIV-infected, resulting in an overall early VT rate of 3.3% (CI 2.5-4.3). The VT rate was significantly associated with the type of maternal exposure to ART (0.5%, 2/439, p<0.001, CI 0.0-1.6) in mothers who commenced HAART before pregnancy, 1.9% (6/321, CI 0.7-4.0) in mothers who commenced HAART during pregnancy, 4.1% (34/837, CI 2.8-5.6) in those on short-course ART and 11.1% (17/153, CI 6.6-17.2) in mothers not receiving ART. On multivariate analysis, the type of exposure to ART remained significantly associated with being small for gestational age (aOR 5.0, CI 2.4-10.3, p < 0.001) and female gender (aOR 2.1, CI 1.2-3.8, p = 0.01). CONCLUSION: The successfully low rate of VT transmission of HIV in mothers who commenced HAART in early pregnancy strongly supports the need to improve access to diagnosis and early treatment of all women of childbearing age with HIV through the national PMTCT programme. ABBREVIATIONS: ANRS: French National Agency for Research on AIDS and Viral Hepatitis; ART: antiretroviral therapy; ARV: antiretroviral; AUDIPOG: Association des Utilisateurs de Dossiers Informatises en Pediatrie, Obstetrique et Gynecologie; CHM/MCC-CBF: The Central Hospital Maternity/Mother and Child Centre of the Chantal Biya Foundation; EHC: Essos Hospital Centre; EPI: Expanded Programme on Immunization; HAART: highly active antiretroviral therapy; HBV: hepatitis B virus; IQR: interquartile range; LH: Laquintinie Hospital; MTCT: mother-to-child transmission; NVP: nevirapine; Pediacam: Pediatrie Cameroun; PMTCT: prevention of mother-to-child transmission; SGAG: small for gestational age and gender; UNAIDS: Joint United Nations Program on HIV/AIDS; WHO: World Health Organization; ZDV: zidovudine; 3TC: lamivudine.
dc.language.isoENen_US
dc.subject.enBiostatistics
dc.title.enLow rate of early vertical transmission of HIV supports the feasibility of effective implementation of the national PMTCT guidelines in routine practice of referral hospitals in Cameroon
dc.title.alternativePaediatr Int Child Healthen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1080/20469047.2019.1585136en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed31017537en_US
bordeaux.journalPaediatrics and International Child Healthen_US
bordeaux.page208-215en_US
bordeaux.volume39en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - UMR 1219en_US
bordeaux.issue3en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
bordeaux.identifier.funderIDAgence Nationale de Recherches sur le Sida et les Hépatites Viralesen_US
hal.identifierhal-03209972
hal.version1
hal.date.transferred2021-04-27T13:50:46Z
hal.exporttrue
bordeaux.COinSctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft.jtitle=Paediatrics%20and%20International%20Child%20Health&amp;rft.date=2019-08&amp;rft.volume=39&amp;rft.issue=3&amp;rft.spage=208-215&amp;rft.epage=208-215&amp;rft.eissn=2046-9055%20(Electronic)%202046-9047%20(Linking)&amp;rft.issn=2046-9055%20(Electronic)%202046-9047%20(Linking)&amp;rft.au=PENDA,%20C.%20I.&amp;TEJIOKEM,%20M.%20C.&amp;SOFEU,%20Casimir&amp;NDIANG,%20S.%20T.&amp;ATEBA%20NDONGO,%20F.&amp;rft.genre=article


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée